The global bicycle market in 2022 was US$ 1,300 million and is estimated to be US$ 2,650.23 million in 2023. The bicycle market is expected to increase at a CAGR of 8.92% between 2023 and 2033, totaling around US$ 6,229.4 million by 2033.

The increase in global bicycle market rises as customers prefer bicycles as a form of leisure increase. Maintaining an active and healthy lifestyle, and a life free from numerous ailments, bicycles are considered to be a handy method of exercise that is in great demand among consumers.

The global dermatology devices market share was valued at US$ 4.6 billion in 2021 and is expected to grow at a CAGR of 6.5% to US$ 9.3 billion by the end of 2032.

Dermatology devices market is a billion dollars market accounting for a substantial proportion of healthcare expenditure globally. Future Market Insights offers a 10-year forecast for the global dermatology devices market and provides insights on the drivers, restraints, opportunities, and trends likely to govern the global dermatology devices market during the forecast period.

Factors such as rising prevalence of skin problems including acne leading to scars, increasing obesity, and growing aesthetic awareness among people are likely to contribute to the revenue growth of the global dermatology devices market over the forecast period. Economic factors such as growing healthcare expenditure, increasing disposable income per capita, and rising government support in developed economies are expected to boost the growth of the global dermatology devices market over the forecast period.

Key Market Segmentation:

The global dermatology devices market is segmented on the basis of Product Type (Lasers, RF Devices, Microdermabrasion Devices, Others); Application (Vascular Lesions, Tattoo Removal, Hair Removal, Wrinkle Removal, Scar Removal, Acne Removal, Others); and End User (Hospitals, Specialty Dermatology Clinics, Private Clinics).

The Lasers product type segment is projected to dominate the global dermatology devices market in terms of value over the forecast period. This segment is anticipated to hold a market value share of 46.5% by the end of 2016
The RF Devices product type segment is expected to be the second most lucrative segment in the global dermatology devices market
The Vascular Lesions application segment is expected to account for 18.2% revenue share of the global dermatology devices market by 2016 end
The Hair Removal application segment is expected to reach US$ 915.6 Mn by 2026 owing to increase in prevalence of polycystic ovarian syndrome in women
The Speciality Dermatology Clinics end user segment is anticipated to reach a market valuation of US$ 2,005.3 Mn by 2026
The Private Clinics end user segment is expected to account for 30.3% revenue share of the global dermatology devices market by 2016 end.
Regional Outlook:

The global dermatology devices market is segmented into the seven key regions of North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and MEA. The demand for non-invasive cosmetic correction procedures has been significantly high in the U.S. market in the recent years, making North America the most lucrative market globally. In addition to North America, demand for non-invasive cosmetic procedures has been significantly growing in Western Europe and APEJ. Western Europe is expected to account for 20.3% revenue share of the global dermatology devices market by 2016 end.

Competitive Landscape:

The global dermatology devices market report profiles some of the leading companies operating in the global dermatology devices market such as Valeant Pharmaceuticals International Inc., Cynosure Inc., Lumenis, Syneron Candela Ltd., Avita Medical Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., Cutera, Lutronics Corporation, and Beijing Toplaser Technology Co. Ltd. Major market players are adopting different strategies such as product launches and acquisitions to maintain their market share. For instance, in November 2015, Lumenis acquired Pollogen to strengthen and expand its aesthetic products portfolio. Similarly, in May 2016, Alma Lasers launched Accent Prime that combines ultrasound and unipolar radio frequency technologies to provide enhanced body contouring and skin tightening treatments.

For more Information @ https://www.futuremarketinsigh....ts.com/reports/derma

Key Segmentation Covered:

By Product Type

Lasers
Fractional
Diode
InfraRed
Alexandrite laser
Nd:YAG
Pulsed
Potassium Titanyl Phosphate (KTP)
RF Devices
Microdermabrasion Devices
Others
By End User

Hospitals
Specialty Dermatology Clinics
Private Clinics
By Application

Vascular Lesions
Tattoo Removal
Hair Removal
Wrinkle Removal
Scar Removal
Acne Removal
Others
By Regions

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
MEA
Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
Detailed insights of market segments and sub-segments for historical as well as forecast period
A competitive analysis of prominent players and emerging players in the keyword market
Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Breast pump market size are predicted to grow at a CAGR of 4.6% from 2022 to 2030, reaching a market worth of US$ 2.45 billion by the end of that year, up from US$ 1.72 billion in 2022.

Report highlights the potential factors fueling the revenue growth of the breast pump market globally. A breast pump is a medical device used to elicit breast milk from lactating women. Breast pump products are available in two models, including manual breast pumps and electrical breast pumps. Electric breast pumps are available in two formats: single electric breast pumps and double electric breast pumps.

This report analyzes total revenue generated through sales of breast pump products, which include manual breast pumps and electric breast pump devices for breast feeding. Breast pump products are increasingly becoming a necessity among working women across the world as the inclusion of women in workforce is increasing globally. Since the last few years, the percentage of working women in workplaces across the globe has been declining (46.2% in 2019 as compared to 50.9% in 1990 as per “Catalyst”).

Breast Pumps Market Segmentation:

By Product Type

Open System Breast Pumps
Closed System Breast Pumps
By Technology Type

Electric Breast Pumps
Single Electric Breast Pumps
Double Electric Breast Pumps
Manual Breast Pumps
By End User

Homecare Settings
Healthcare Facilities
By Region

North America
Latin America
Western Europe
Eastern Europe
Japan
Asia Pacific Excluding Japan (APEJ)
Middle East & Africa (MEA)
For more Information @ https://www.futuremarketinsigh....ts.com/reports/breas

Emerging economies are witnessing impressive growth in healthcare spending. This can be attributed to improvements in healthcare technology and changing lifestyle, which is fueling the demand for breast pumps among urban women. According to WHO, the global healthcare spending rose by 2.4% in 2014 over 2013. Healthcare spending is growing at a rate of 5% in developing regions. Rise in healthcare expenditure is expected to boost overall adoption of breast pumps among women, especially in Asia Pacific.

Breast pump adoption is as high as 85% among breast feeding women at 3 months post-birth. Furthermore, marketplace discussions indicate that the availability of breast pump accessory products will also encourage the adoption of electric breast pumps in developed markets. In this regard, infant product manufacturers are increasingly bundling other pump-related products, such as nursing bras and breast pumping bras, to sell complete package of breast pumps, which is anytime more profitable than isolated sales. Electrical breast pump packages find more adoption than manual breast pump products due to ****ter volume of output. These innovative solutions are projected to fuel breast pump market revenues in the global electric breast pumps market during the forecast period.

Key Market Players:

Koninklijke Philips N.V.,
Pigeon Corporation,
Newell Brands,
Medela Inc.,
Ameda Inc.,
Hygeia II Medical Group Inc.,
Bailey Medical,
Mayborn Group Ltd. and Linco Baby Merchandise Works Co., Ltd.
Others
The Electric breast pump market is more technologically advanced with higher product pricing and low penetration. This category of breast pump comprises few global breast pump manufacturing companies. Potential new entrants in breast pump market are trying to capture and improve their market position by using innovative marketing strategies, such as inorganic growth. Breast pump manufacturers are expanding their product portfolio using latest technologies.

Availability of BPA free breast pump products is fuelling breast pump adoption in developed as well as more the affluent markets in developing regions. In the recent past, breast pump manufacturers have begun offering bisphenol A or BPA-free breast pump products to increase sales. BPA is a chemical used to make milk container or feeding bottle rigid and more resistant and has been associated with adverse health effects, such as neural and fertility issues. Examples of some BPA free breast pump products are Philips Avent Manual Comfort Breast Pump from Koninklijke Philips N.V. and BPA-free breast pumps by Medela, Inc.

Rapid rise in promotional/supporting campaigns for Breast Pump products is fuelling revenue growth of the breast pump market. In November 2012, leading breast pump manufacturer Medela launched a campaign titled ‘Virtual Human Milk Collection Campaign’ to commemorate Prematurity Awareness Month, where the breast pump manufacturer encouraged and demonstrated the importance of breast milk for infants and babies. Medela has also donated US$ 30,000 worth of breastfeeding related products to various neonatal intensive care units across the U.S.

The body contouring market size is anticipated to grow at a CAGR of 6.9% from 2022 to 2032, rising from US$ 7.3 billion in 2022 to US$ 11.1 billion in valuation by 2032.

The team of analysts at Future Market Insights are focusing on research and market study to produce different Body Contouring Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Body Contouring Market.

Top Market Players:

Key players operating in the body contouring market are –

GlobalMed Technologies
Chromogenex, Human Med.
Wells Johnson Company
Invasix Aesthetic Solutions
Erchonia
Fotona
Cutera
BTL Industries
Meridian
Palomar Medical Technologies
Others
Key Market Segmentation Covered in the Study:

By Invasiveness:

Non-Invasive Contouring
Minimally Invasive Contouring
Invasive Contouring
By End-user:

Hospitals
Ambulatory surgical centers
Medical Spa
Clinics
By Regions:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Europe (Germany, Italy, France, U.K, Spain, , Russia)
East Asia (China, Japan, South Korea)
South Asia (India, ASEAN)
Oceania (Australia, New Zealand)
Middle East and Africa (GCC Countries, South Africa, Northern Africa)
For more Information @ https://www.futuremarketinsigh....ts.com/reports/body-

Important changes in Market Dynamics:

The report has been created after detailed and exhaustive studies by the analysts at FMI taking several factors into consideration like monetary, ecological, social, mechanical, and political status of a particular demography. They study the key data to assess the revenue and production of manufacturers across various regions. The report also covers an in-depth analysis of the key changes in market dynamics in the recent past and the near future.

Segmentation details of the market

Former, on-going, and projected market analysis in terms of volume and value
Assessment of niche industry developments
Market share analysis
Key strategies of major players
Emerging segments and regional markets

The global nuclear medicine equipment market size is expected to expand from US$ 2.3 billion in 2022 to US$ 3.4 billion in 2032. The nuclear medicine equipment market grew at a CAGR of 3.6 percent from 2016 to 2021, resulting in a market size of US$ 2.2 billion in 2021.

One of the primary aspects driving the nuclear medicine equipment market's favourable outlook is the rising prevalence of chronic medical conditions around the world.

Furthermore, the growing elderly population, which is more susceptible to age-related and linked disorders, is propelling the sales of nuclear medicine equipment forward. In line with this, the growing demand for tailored medications among healthcare professionals and patients is fuelling the nuclear medicine equipment market's expansion.

Other growth-inducing aspects include technology improvements such as the introduction of data integrated imaging systems and radiotracers. These systems allow for the reconstruction and processing of computer-assisted pictures as well as the accurate recognition of medical diseases in order to compare diagnostic scans and track illness development. These are driving the nuclear medicine equipment market trends globally.

As per nuclear medicine equipment market analysis, in order to provide precise and high-resolution images, healthcare facilities are rapidly transitioning from standalone to hybrid imaging technologies. Other factors, such as increased biotechnology research and development (R&D) activities, as well as major advances in medical infrastructure, particularly in developing nations, are expected to propel the nuclear medicine equipment market forward.

For more Information @ https://www.futuremarketinsigh....ts.com/reports/nucle

The global nuclear medicine equipment market is expected to grow due to an increase in the prevalence of chronic diseases such as cancer and cardiovascular diseases, increased awareness of the efficacy of nuclear medicine equipment for early diagnosis of various types of cancers, and technological advancements.

However, the expensive cost of nuclear medicine equipment and the absence of reliable data and proof are limiting the nuclear medicine equipment market's expansion. Increased investments in research and technical breakthroughs, on the other hand, will open up new prospects in the coming years and change the nuclear medicine equipment market outlook.

Key Takeaways:

The nuclear medicine equipment market growth is likely to be hampered by high installation and running expenses, as well as product recalls, over the forecast period.
One of the primary reasons projected to drive nuclear medicine equipment market expansion over the forecast period is the rising prevalence of chronic disorders.
SPECT segment leads the nuclear medicine equipment market share with the projected CAGR of 4.92% by 2032.
Oncology leads the nuclear medicine equipment market with the projected CAGR of 4.3% by 2032.
From 2021 to 2032, the academic and research institutes segment is expected to grow at the fastest rate of 6.1 percent. This is attributable to an increase in nuclear medicine research and development activities.
Competitive Landscape:

To enhance their nuclear medicine equipment market share, leading players in the worldwide nuclear medical equipment market are focused on new product introductions. Several companies are prioritising new releases, product approvals, and other organic growth techniques like patents and events.

In the nuclear medicine equipment market, acquisitions, partnerships, and collaborations were viewed as inorganic growth strategies. These initiatives have paved the road for market players to develop their business and client base and transform the nuclear medical equipment market picture.

Key Players in the nuclear medicine equipment companies include Philips Healthcare, GE Healthcare, Siemens Healthineers AG, Digirad Corporation, Mediso Medical Imaging Systems Ltd, DDD-Diagnostics A/S, Neusoft Medical Systems Co. Ltd., SurgicEye GmbH, and CMR Naviscan Corporation.

With high entry hurdles, advanced technical advances, and significant clinical and nonclinical unmet needs to meet, the nuclear medicine equipment market appears to have a bright future.

Recent Development in the Nuclear Medicine Equipment Market:

Curium purchased IASON, an Austrian radiopharmaceutical company, in June 2021 to expand its diagnostic product portfolio in Europe.

Lantheus, a company that makes diagnostic imaging agents and equipment in the United States, received FDA approval for PYLARIFY injectable in May 2021. The injection is the first commercially available PSMA PET imaging agent for prostate cancer.

Key Segments

By Product:

SPECT
Hybrid SPECT
Standalone SPECT
Hybrid PET
Planar Scintigraphy
By Application:

Oncology
Cardiology
Neurology
Others
By End User:

Hospitals
Imaging Centers
Academic & Research Institutes
Others
By Region:

North America
Europe
Asia Pacific
MEA
Latin America